Fujian Aonong Biological Technology Group Incorporation Limited (603363.SS)
Xiamen, CN
Fujian Aonong Biological Technology Group Incorporation Limited operates across diverse sectors, including animal feed production, swine farming, agricultural raw material trading, digital agricultural platforms, and bio-pharmaceuticals, serving both domestic Chinese and international markets. Its activities encompass the research, development, manufacturing, and distribution of various animal feed products, including specialized formulations for pigs, poultry, aquatic species, and ruminants. Furthermore, the company manages pig breeding facilities and is involved in the processing and slaughtering of swine. Aonong Biological Technology also supplies a range of veterinary products, such as vaccines, medicinal preparations, micro-ecological agents, powdered supplements, premixes, liquid oral treatments, feed additives, and disinfectants. Additionally, it develops and maintains an intelligent platform designed to support breeding services. Established in Xiamen, China, the company commenced operations in 2011.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.15% | -4.72% | -4.72% | -23.64% | -34.22% | -29.93% | -13.87% | -66.25% | -69.24% | -39.14% | -39.14% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Agricultural Farm Products: +8.2%-3.3% Q1'26: +23.7% (vs Q1'25)
-
EPS growth Agricultural Farm Products: +20.0%-95.5% Q1'26: -104.0% (vs Q1'25)
-
FCF margin FCF growth · Agricultural Farm Products: +43.8%-6.2% Q1'26: -7.2% (vs Q1'25)
-
EBIT margin Agricultural Farm Products: +8.1%+2.9% Q1'26: -0.6% (vs Q1'25)
-
ROIC Agricultural Farm Products: +6.0%+4.6% Q1'26: -0.9% (vs Q1'25)
-
Share dilution Agricultural Farm Products: +0.0%+199.2% Q1'26: +54.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Farm Products: 0.61×2.42× Q1'26: -46.67× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|---|---|---|---|---|
| Revenue |
5.76B
est: 5.50B (+4.7%)
|
5.79B
est: 5.79B (+0.0%)
|
11.52B
est: 11.52B (+0.0%)
|
18.04B
est: 15.29B (+18.0%)
|
21.61B
est: 23.15B (-6.6%)
|
19.46B
est: 26.63B (-26.9%)
|
8.76B
est: 31.99B (-72.6%)
|
8.47B
est: 34.52B (-75.5%)
|
| EBITDA |
195.42M
est: -12.50M (+1,663.2%)
|
333.43M
est: -13.15M (+2,635.4%)
|
1.49B
est: -26.17M (+5,796.2%)
|
-574.94M
est: -34.74M (-1,554.9%)
|
232.72M
est: -52.60M (+542.4%)
|
-1.78B
est: -60.50M (-2,836.0%)
|
-248.73M
est: -355.90M (+30.1%)
|
721.66M
est: -384.08M (+287.9%)
|
| EBIT |
90.36M
est: -252.13M (+135.8%)
|
178.00M
est: -265.23M (+167.1%)
|
1.16B
est: -527.76M (+320.4%)
|
-1.27B
est: -700.68M (-81.5%)
|
-628.17M
est: -1.06B (+40.8%)
|
-2.60B
est: -1.22B (-113.1%)
|
-849.59M
est: -1.92B (+55.9%)
|
248.53M
est: -2.08B (+112.0%)
|
| Net Income |
30.13M
est: 59.86M (-49.7%)
|
29.16M
est: 46.56M (-37.4%)
|
572.99M
est: 734.99M (-22.0%)
|
-1.52B
est: -1.33B (-14.1%)
|
-1.04B
est: 8.65M (-12,108.5%)
|
-3.65B
est: -821.46M (-344.4%)
|
579.35M
est: 4.37B (-86.8%)
|
77.62M
est: 4.04B (-98.1%)
|
| SGA |
543.58M
est: 370.65M (+46.7%)
|
434.41M
est: 389.92M (+11.4%)
|
649.66M
est: 775.86M (-16.3%)
|
920.96M
est: 1.03B (-10.6%)
|
1.06B
est: 1.56B (-32.3%)
|
1.06B
est: 1.79B (-40.8%)
|
1.10B
est: 1.88B (-41.4%)
|
118.92M
est: 2.03B (-94.2%)
|
| EPS |
0.06
est: 0.07 (-20.3%)
|
0.05
est: 0.05 (-0.8%)
|
0.95
est: 0.85 (+11.8%)
|
-2.76
est: -1.54 (-79.3%)
|
-1.34
est: 0.01 (-13,500.0%)
|
-4.21
est: -0.95 (-343.2%)
|
0.67
est: 1.69 (-60.4%)
|
0.03
est: 1.56 (-98.1%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-26 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-25 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-19 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-18 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-14 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-23 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 1/5 | 5/5 | 5/5 | 1/5 | 4/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jiang Peng | Deputy GM & Secretary of the Board | — | male |
| Jianping Yang | Accounting Supervisor | — | — |
| Qiang Lin | Deputy GM, Vice President of Food Industry & President of Xiamen Yinxiang Meat | — | male |
| Shao Yong Hu | Deputy General Manager | — | male |
| You Lin Wu | Vice Chairman & GM | — | male |
| Zhou Yang | Vice General Manager & CFO | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603363.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
